To select appropriate OC cell lines for further in vitro and in vivo evaluation, we examined the expression of HER2, VEGFR2, and VEGFR3 in four OC cell lines and one bladder cancer cell line using Western blot and immunofluorescence assays. The gene discussed is FLT4; the disease is urinary bladder carcinoma.